AMN Healthcare Services (NYSE:AMN) Given New $35.00 Price Target at UBS Group

Key Points

• UBS raised its price target for AMN Healthcare Services from $32 to $35 while maintaining a neutral rating; the target implies 2.59% downside from the prior close. The broader analyst consensus remains “Hold,” with a $30.86 target.
• AMN shares climbed 16.7% to $35.93, near their 12-month high, following strong quarterly results. Adjusted EPS of $0.77 and revenue of $673.24 million significantly exceeded analyst estimates, while revenue rose 2.3% year over year.
• Management’s third-quarter revenue outlook exceeded expectations, with guidance of $640 million to $655 million versus consensus of $618.4 million. Growth was supported by travel nursing, allied healthcare staffing and executive search, though the company continues to report a negative net margin.

AMN Healthcare Services (NYSE:AMN - Get Free Report) had its price objective lifted by investment analysts at UBS Group from $32.00 to $35.00 in a note issued to investors on Friday,Benzinga reports. The firm currently has a "neutral" rating on the stock. UBS Group's price objective indicates a potential downside of 2.59% from the stock's previous close.

Several other equities analysts have also commented on the company. Truist Financial upped their target price on AMN Healthcare Services from $26.00 to $40.00 and gave the company a "buy" rating in a research note on Wednesday, July 22nd. Zacks Research lowered AMN Healthcare Services from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, May 20th. BMO Capital Markets lifted their price target on AMN Healthcare Services from $25.00 to $26.00 and gave the company an "outperform" rating in a report on Monday, May 11th. Citizens Jmp reaffirmed a "market outperform" rating and set a $36.00 price objective on shares of AMN Healthcare Services in a research note on Tuesday, June 23rd. Finally, Robert W. Baird set a $36.00 price objective on shares of AMN Healthcare Services in a report on Friday. Four equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, AMN Healthcare Services presently has a consensus rating of "Hold" and a consensus price target of $30.86.

AMN Healthcare Services Trading Up 16.7%

AMN stock traded up $5.13 during midday trading on Friday, hitting $35.93. The stock had a trading volume of 1,517,139 shares, compared to its average volume of 1,143,268. The company's 50-day moving average price is $32.37 and its 200 day moving average price is $25.01. The company has a debt-to-equity ratio of 1.04, a current ratio of 1.09 and a quick ratio of 1.09. The firm has a market cap of $1.39 billion, a PE ratio of -41.30, a price-to-earnings-growth ratio of 0.75 and a beta of 0.40. AMN Healthcare Services has a 12-month low of $14.86 and a 12-month high of $36.86.

AMN Healthcare Services (NYSE:AMN - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.77 earnings per share for the quarter, topping analysts' consensus estimates of $0.19 by $0.58. AMN Healthcare Services had a positive return on equity of 18.01% and a negative net margin of 0.95%.The company had revenue of $673.24 million for the quarter, compared to analyst estimates of $628.39 million. During the same quarter in the prior year, the company posted $0.30 EPS. The business's revenue for the quarter was up 2.3% compared to the same quarter last year. On average, equities research analysts predict that AMN Healthcare Services will post 2.7 earnings per share for the current fiscal year.

Insider Activity at AMN Healthcare Services

In related news, Director Mark G. Foletta sold 3,681 shares of the stock in a transaction on Monday, June 15th. The stock was sold at an average price of $31.07, for a total value of $114,368.67. Following the transaction, the director directly owned 17,917 shares of the company's stock, valued at approximately $556,681.19. This trade represents a 17.04% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.07% of the stock is currently owned by insiders.

Institutional Investors Weigh In On AMN Healthcare Services

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Empowered Funds LLC boosted its position in AMN Healthcare Services by 411.6% during the 1st quarter. Empowered Funds LLC now owns 268,007 shares of the company's stock worth $4,915,000 after purchasing an additional 215,623 shares during the period. Burney Co. purchased a new position in AMN Healthcare Services in the first quarter valued at about $4,152,000. FourThought Financial Partners LLC acquired a new position in shares of AMN Healthcare Services during the fourth quarter worth about $293,000. Arrowstreet Capital Limited Partnership lifted its stake in shares of AMN Healthcare Services by 1,278.0% during the first quarter. Arrowstreet Capital Limited Partnership now owns 1,401,725 shares of the company's stock worth $25,708,000 after purchasing an additional 1,300,005 shares in the last quarter. Finally, Readystate Asset Management LP boosted its position in shares of AMN Healthcare Services by 127.5% in the first quarter. Readystate Asset Management LP now owns 79,115 shares of the company's stock worth $1,451,000 after buying an additional 44,337 shares during the period. 99.23% of the stock is currently owned by institutional investors and hedge funds.

More AMN Healthcare Services News

Here are the key news stories impacting AMN Healthcare Services this week:

• Positive Sentiment: Quarterly earnings and revenue topped estimates. AMN reported adjusted EPS of $0.77, up from $0.30 a year earlier and well above analysts’ expectations of approximately $0.19-$0.22. Revenue rose 2.3% year over year to $673 million, exceeding the roughly $628 million consensus estimate. GAAP earnings were $0.53 per share, while adjusted EBITDA totaled $73 million. AMN Healthcare Announces Second Quarter 2026 Results
• Positive Sentiment: Growth was broad-based across staffing and search services. Results benefited from higher demand in travel nursing, allied healthcare staffing and executive search, along with activity related to labor disruptions. The earnings beat suggests AMN is gaining operating leverage as demand stabilizes. AMN Q2 Earnings Beat Estimates on Staffing and Search Growth
• Positive Sentiment: Third-quarter revenue guidance exceeded expectations. Management forecast Q3 revenue of $640 million to $655 million, above the consensus estimate of $618.4 million. Although the range implies a sequential decline from Q2, it indicates stronger near-term demand than analysts had projected. AMN Healthcare Quarterly Earnings Report
• Neutral Sentiment: The company continues to face a challenging staffing environment, including a negative reported net margin, while investors will watch whether the recent earnings strength can persist after labor-disruption-related activity.

AMN Healthcare Services Company Profile

AMN Healthcare Services, Inc NYSE: AMN is a leading provider of healthcare workforce solutions in the United States. The company specializes in staffing and recruitment services for a broad range of clinical and allied health professionals, including travel nurses, permanent placement of nursing staff, locum tenens physicians, and allied health personnel. In addition to direct staffing, AMN Healthcare offers comprehensive workforce management solutions such as vendor management systems (VMS), recruitment process outsourcing (RPO), and compliance and credentialing services through its technology platforms.

Founded in 1985 as American Mobile Nurses, the company rebranded to AMN Healthcare in 2010 to reflect its expanding portfolio of services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source